Pegylated rhG-CSF

pegfilgrastim · Jiangsu HengRui Medicine Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Pegylated rhG-CSF, covering 2012-11-06 to 2012-11-06. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Pegylated rhG-CSF as Support to Advanced Non-Small-Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy Receiving Chemotherapy [Phase 3]

See pricing